|
|
药学学报, 2021, 56(1): 190-200 |
|
|
引用本文： |
|
|
张誉馨, 张锐, 杨静, 闪雪纯, 梁秀睿, 张怡, 徐凡, 金佳琦, 关晶, 傅继华. 2型糖尿病引起的疲劳与骨骼肌5-羟色胺降解的相关性研究[J]. 药学学报, 2021, 56(1): 190-200. |
|
|
ZHANG Yu-xin, ZHANG Rui, YANG Jing, SHAN Xue-chun, LIANG Xiu-rui, ZHANG Yi, XU Fan, JIN Jia-qi, GUAN Jing, FU Ji-hua. Relationship between fatigue caused by type 2 diabetes mellitus and 5-HT degradation in skeletal muscle[J]. Acta Pharmaceutica Sinica, 2021, 56(1): 190-200. |
|
|
|
|
|
|
|
| 2型糖尿病引起的疲劳与骨骼肌5-羟色胺降解的相关性研究 |
|
| 张誉馨, 张锐, 杨静, 闪雪纯, 梁秀睿, 张怡, 徐凡, 金佳琦, 关晶, 傅继华 |
|
| 中国药科大学基础医学与临床药学学院, 江苏 南京 210009 |
| 摘要: |
| 疲劳是2型糖尿病（T2DM）常见的并发症。本文研究了T2DM性疲劳与骨骼肌5-羟色胺（5-HT）系统的关系。动物实验用高脂饲料喂养结合腹腔注射链脲佐菌素建立小鼠T2DM模型，用5-HT2A受体（5-HT2AR）拮抗剂盐酸沙格雷酯（SH）及5-HT合成抑制剂卡比多巴（CDP）分别或联合给药治疗。细胞实验用D-葡萄糖、棕榈酸或5-HT刺激C2C12细胞。用SH、CDP或单胺氧化酶A（MAO-A）抑制剂氯吉兰分别抑制5-HT2AR、5-HT合成及5-HT降解。本文中动物福利和实验过程均遵循中国药科大学动物伦理委员会的规定。结果表明，小鼠骨骼肌及C2C12细胞均存在5-HT2AR、5-HT合成酶及MAO-A表达。T2DM以及棕榈酸、D-葡萄糖刺激C2C12细胞时，它们的表达明显上调，且棕榈酸是比D-葡萄糖更敏感的刺激它们表达的因子。转棒实验及生化指标检测均表明，T2DM性疲劳起因于骨骼肌5-HT2AR、5-HT合成及5-HT降解的增加。5-HT2AR通过介导MAO-A表达、5-HT合成，间接调控5-HT降解。而MAO-A通过介导5-HT降解，调控细胞炎症、线粒体的ROS产生及膜电位去极化，还抑制过氧化物酶体增殖物激活受体-γ共激活因子-1（PGC-1）、肉碱棕榈酰转移酶1（CPT1）及ATP合成酶6（ATP6）表达，从而抑制线粒体功能，如脂肪酸β氧化和ATP合成。用SH和CDP可有效地治疗T2DM性疲劳，同时也可降血糖和血脂，且联合给药有明显的协同效应。 |
| 关键词:
糖尿病性疲劳
骨骼肌
5-HT2A受体
5-HT合成
线粒体5-HT降解
线粒体ATP合成
|
|
| Relationship between fatigue caused by type 2 diabetes mellitus and 5-HT degradation in skeletal muscle |
|
| ZHANG Yu-xin, ZHANG Rui, YANG Jing, SHAN Xue-chun, LIANG Xiu-rui, ZHANG Yi, XU Fan, JIN Jia-qi, GUAN Jing, FU Ji-hua |
|
| School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China |
| Abstract: |
| Fatigue is a common complication of type 2 diabetes mellitus (T2DM). We examined the relationship between T2DM fatigue and the skeletal muscle 5-hydroxytryptamine (5-HT) system. In animal experiments, a T2DM model was established in mice by feeding a high-fat diet with intraperitoneal injection of streptozotocin. The mice were treated with the 5-HT2A receptor antagonist sarpogrelate hydrochloride (SH) and the 5-HT synthesis inhibitor carbidopa (CDP) (separately and in combination). In cell culture experiments, C2C12 cells were stimulated with D-glucose, palmitic acid or 5-HT. 5-HT2AR, 5-HT synthesis and 5-HT degradation were inhibited by SH, CDP, or monoamine oxidase A (MAO-A) inhibitor. The animal experiments were in accordance with the regulations of the Animal Ethics Committee of China Pharmaceutical University. The results showed that 5-HT2AR, 5-HT synthase and MAO-A were expressed in mouse skeletal muscle and C2C12 cells. The expression of these proteins was significantly up-regulated in T2DM mice or when C2C12 cells were exposed to palmitic acid and D-glucose; palmitic acid was a stronger stimulant of their expression than D-glucose. Rotating rod experiments and biochemical index tests have shown that T2DM fatigue is associated with an increase in skeletal muscle 5-HT2AR, 5-HT synthesis and 5-HT degradation. 5-HT2AR mediates the expression of MAO-A and the synthesis of 5-HT, which indirectly regulates the degradation of 5-HT. MAO-A regulates cell inflammation, mitochondrial ROS production and membrane potential depolarization by mediating 5-HT degradation. MAO-A also inhibits the expression of peroxisome proliferator-activated receptor γ coactivator-1 (PGC-1), carnitine palmitoyltransferase-1 (CPT1) and ATP synthase-6 (ATP6), thus inhibiting mitochondrial functions such as fatty acid β oxidation and ATP synthesis. SH and CDP can effectively treat T2DM fatigue, and can also reduce blood glucose and blood lipid, and the combination of SH and CDP has a clear synergistic effect. |
| Key words:
diabetes-related fatigue
skeletal muscle
5-HT2A receptor
5-HT synthesis
5-HT degradation in the mitochondria
ATP synthesis in the mitochondria
|
|
| 收稿日期: 2020-08-24
|
| DOI: 10.16438/j.0513-4870.2020-1403 |
| 基金项目: 国家自然科学基金资助项目（81570720）；中国药科大学“双一流”学科创新团队建设项目（CPU2018GY23）；江苏省研究生科研创新计划项目（KYCX19_0690）. |
通讯作者: 傅继华,E-mail:fjhfy_cpu@163.com
Email: fjhfy_cpu@163.com |
|
| 相关功能 |
|
|
|
|
| 作者相关文章 |
|
| 张誉馨 在本刊中的所有文章 |
| 张锐 在本刊中的所有文章 |
| 杨静 在本刊中的所有文章 |
| 闪雪纯 在本刊中的所有文章 |
| 梁秀睿 在本刊中的所有文章 |
| 张怡 在本刊中的所有文章 |
| 徐凡 在本刊中的所有文章 |
| 金佳琦 在本刊中的所有文章 |
| 关晶 在本刊中的所有文章 |
| 傅继华 在本刊中的所有文章 |
|
|
|
|
|
|
|
|
参考文献: |
|
|
[1] Gandevia SC. Spinal and supraspinal factors in human muscle fatigue[J]. Physiol Rev, 2001, 81:1725-1789.
[2] Zhu XX, Duan XH, Li RX, et al. Research progress on the relationship between mitochondrial dysfunction and non-alcoholic fatty liver disease[J]. Shandong Med (山东医药), 2018, 58:108-111.
[3] Ripsin CM, Kang H, Urban RJ. Management of blood glucose in type 2 diabetes mellitus[J]. Am Fam Physician, 2009, 79:29-36.
[4] Jain A, Sharma R, Choudhary PK, et al. Study of fatigue, depression, and associated factors in type 2 diabetes mellitus in industrial workers[J]. Ind Psychiatry J, 2015, 24:179-184.
[5] Young SN. How to increase serotonin in the human brain without drugs[J]. J Psychiatry Neurosci, 2007, 32:394-399.
[6] Cote F, Thevenot E, Fligny C, et al. Disruption of the nonneuronal Tph1 gene demonstrates the importance of peripheral serotonin in cardiac function[J]. Proc Natl Acad Sci U S A, 2003, 100:13525-13530.
[7] Boess FG, Martin IL. Molecular biology of 5-HT receptors[J]. Neuropharmacology, 1994, 33:275-317.
[8] Uchiyama S, Ozaki Y, Satoh K, et al. Effect of sarpogrelate, a 5-HT2A antagonist, on platelet aggregation in patients with ischemic stroke:clinical-pharmacological dose-response study[J]. Cerebrovasc Dis, 2007, 24:264-270.
[9] Shiba T, Yokota A, Gamoh S, et al. Diabetes mellitus induces hyperreactivity of 5-hydroxytryptamine (5-HT)-induced constriction in human internal thoracic artery and is associated with increase in the membrane protein level of 5-HT2A receptor[J]. Biol Pharm Bull, 2018, 41:820-823.
[10] Yamada K, Niki H, Nagai H, et al. Serotonin potentiates high-glucose-induced endothelial injury:the role of serotonin and 5-HT2A receptors in promoting thrombosis in diabetes[J]. J Pharmacol Sci, 2012, 119:243-250.
[11] Su Y, Mao N, Li M, et al. Sarpogrelate inhibits the expression of ICAM-1 and monocyte-endothelial adhesion induced by high glucose in human endothelial cells[J]. Mol Cell Biochem, 2013, 373:195-199.
[12] Walther DJ, Peter JU, Winter S, et al. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release[J]. Cell, 2004, 115:851-862.
[13] Ruddell RG, Mann DA, Ramm GA. The function of serotonin within the liver[J]. J Hepatol, 2008, 48:666-675.
[14] Berger M, Gray JA, Roth BL. The expanded biology of serotonin[J]. Annu Rev Med, 2009, 60:355-366.
[15] Li X, Guo K, Li T, et al. 5-HT2 receptor mediates high-fat diet-induced hepatic steatosis and very low density lipoprotein overproduction in rats[J]. Obes Res Clin Pract, 2016, 12:16-28.
[16] Fu J, Ma S, Li X, et al. Long-term stress with hyperglucocorticoidemia-induced hepatic steatosis with VLDL overproduction is dependent on both 5-HT2 receptor and 5-HT synthesis in liver[J]. Int J Biol Sci, 2016, 12:219-234.
[17] Fu J, Li C, Zhang G, et al. Crucial roles of 5-HT and 5-HT2 receptor in diabetes-related lipid accumulation and pro-inflammatory cytokine generation in hepatocytes[J]. Cell Physiol Biochem, 2018, 48:2409-2428.
[18] Li T, Guo K, Qu W, et al. Important role of 5-hydroxytryptamine in glucocorticoid-induced insulin resistance in liver and intra-abdominal adipose tissue of rats[J]. J Diabetes Investig, 2016, 7:32-41.
[19] Ma S, Li T, Guo K, et al. Effective treatment with combination of peripheral 5-hydroxytryptamine synthetic inhibitor and 5-hydroxytryptamine 2 receptor antagonist on glucocorticoid-induced whole-body insulin resistance with hyperglycemia[J]. J Diabetes Investig, 2016, 7:833-844.
[20] Xu Y, Liu YX, Li X, et al. Experimental study of the effect of Shenhong tablets on the behavior and 5-HT content of chronic fatigue model rats[J]. Ginseng Res (人参研究), 2016, 28:19-21.
[21] Shi SD, Zhou MW, Li JJ, et al. Effect of Yixinle oral liquid on animal behavior and neuroendocrine of chronic stress fatigue model[J]. Chin New Drugs Clin Pharmacol (中药新药与临床药理), 2004, 15:320-322.
[22] Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes[J]. Science, 2005, 307:384-387.
[23] Shih JC, Chen K, Ridd MJ. Monoamine oxidase:from genes to behavior[J]. Annu Rev Neurosci, 1999, 22:197-217.
[24] Pontoriero M, Fiume G, Vecchio E, et al. Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α[J]. J Mol Med (Berl), 2019, 97:675-690.
[25] Schlaepfer IR, Rider L, Rodrigues LU, et al. Lipid catabolism via CPT1 as a therapeutic target for prostate cancer[J]. Mol Cancer Ther, 2014, 13:2361-2371.
[26] Dautant A, Meier T, Hahn A, et al. ATP synthase diseases of mitochondrial genetic origin[J]. Front Physiol, 2018, 9:329.
[27] Valero T. Mitochondrial biogenesis:pharmacological approaches[J]. Curr Pharm Des, 2014, 20:5507-5509.
[28] Gong QL, Li X, Lu Y. Research progress of mitochondrial mechanism in oxidative stress-related diseases[J]. Chin J Cell Biol (中国细胞生物学学报), 2013, 35:1540-1545.
[29] Mitchell P, Moyle J. Chemiosmotic hypothesis of oxidative phosphorylation[J]. Nature, 1967, 213:137-139.
[30] Yang H, Jin X, Kei Lam CW, et al. Oxidative stress and diabetes mellitus[J]. Clin Chem Lab Med, 2011, 49:1773-1782.
[31] Drivsholm T, Olivarius NDF, Nielsen ABS, et al. Symptoms, signs and complications in newly diagnosed type 2 diabetic patients, and their relationship to glycaemia, blood pressure and weight[J]. Diabetologia, 2005, 48:210-214.
[32] Cartoni R, Léger B, Hock MB, et al. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise[J]. J Physiol, 2005, 567:349-358.
[33] Johri A, Chandra A, Flint Beal M. PGC-1α, mitochondrial dysfunction, and Huntington's disease[J]. Free Radic Biol Med, 2013, 62:37-46.
[34] Moniruzzaman M, Ghosal I, Das D, et al. Melatonin ameliorates H2O2-induced oxidative stress through modulation of Erk/Akt/NFκB pathway[J]. Biol Res, 2018, 51:17.
[35] Ren DL, Wang HK, Liu JQ, et al. ROS-induced ZNF580 expression:a key role for H2O2/NF-κB signaling pathway in vascular endothelial inflammation[J]. Mol Cell Biochem, 2012, 359:183-191.
[36] Weiner ID, Verlander JW. Role of NH3 and NH4+ transporters in renal acid-base transport[J]. Am J Physiol Renal Physiol, 2011, 300:F11-F23.
[37] Moser H. Electrophysiological evidence for ammonium as a substitute for potassium in activating the sodium pump in a crayfish sensory neuron[J]. Can J Physiol Pharmacol, 1987, 65:141-145.
[38] Braissant O, McLin VA, Cudalbu C. Ammonia toxicity to the brain[J]. J Inherit Metab Dis, 2013, 36:595-612.
[39] Zorova LD, Popkov VA, Plotnikov EY, et al. Mitochondrial membrane potential[J]. Anal Biochem, 2018, 552:50-59.
[40] Xu T, Li H, Lu SS, et al. Research progress of mitochondrial electron transport respiratory chain and its biological significance[J]. J Fudan Univ (Med Ed) (复旦学报(医学版)), 2015, 42:250-255, 261. |
|
|
|
|
|
|
|
|
|
|
|
|